Achievement of Tolerance Induction to Prevent Acute Graft-vs.-Host Disease

被引：25

作者：

Thangavelu, Govindarajan ^{[1
]}

Blazar, Bruce R. ^{[1
]}

机构：

[1] Univ Minnesota, Dept Pediat, Masonic Canc Ctr, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA

来源：

FRONTIERS IN IMMUNOLOGY | 2019年 / 10卷

基金：

美国国家卫生研究院; 加拿大健康研究院;

关键词：

graft-vs.-host disease; immune tolerance; alpha-1; antitrypsin; allogeneic hematopoietic stem cell transplantation; T regulatory cells; REGULATORY T-CELLS; BONE-MARROW-TRANSPLANTATION; MINOR HISTOCOMPATIBILITY BARRIERS; CHAIN FATTY-ACIDS; ACUTE GVHD; IN-VIVO; POSTTRANSPLANTATION CYCLOPHOSPHAMIDE; ANTITHYMOCYTE GLOBULIN; VERSUS-LEUKEMIA; GUT MICROBIOTA;

D O I：

10.3389/fimmu.2019.00309

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Acute graft-vs.-host disease (GVHD) limits the efficacy of allogeneic hematopoietic stem cell transplantation (allo-HSCT), a main therapy to treat various hematological disorders. Despite rapid progress in understanding GVHD pathogenesis, broad immunosuppressive agents are most often used to prevent and remain the first line of therapy to treat GVHD. Strategies enhancing immune tolerance in allo-HSCT would permit reductions in immunosuppressant use and their associated undesirable side effects. In this review, we discuss the mechanisms responsible for GVHD and advancement in strategies to achieve immune balance and tolerance thereby avoiding GVHD and its complications.

引用

页数：17

共 50 条

[41] The ex vivo toll-like receptor 7 tolerance induction in donor lymphocytes prevents murine acute graft-versus-host disease
Zogas, Nikolaos
Karponi, Garyfalia
Iordanidis, Fotios
Malasidis, Stylianos
Paraskevas, Vasilios
Papadopoulou, Anastasia
Scouras, Zaharias George
Anagnostopoulos, Achilles
Yannaki, Evangelia
CYTOTHERAPY, 2018, 20 (01) : 149 - 164
[42] PREVENTION AND TREATMENT OF ACUTE GRAFT-VS-HOST DISEASE
PIETRYGA, D
AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1993, 15 (01): : 28 - 48
[43] Graft vs host disease
Moalic, V.
Ferec, C.
PATHOLOGIE BIOLOGIE, 2006, 54 (05): : 304 - 308
[44] Adoptive transfer of murine syngeneic graft-vs.-host disease by CD4+ T cells
Bryson, J. Scott
Jennings, C. Darrell
Brandon, Jason A.
Perez, Jacqueline
Caywood, Betty E.
Kaplan, Alan M.
JOURNAL OF LEUKOCYTE BIOLOGY, 2007, 82 (06) : 1393 - 1400
[45] Acute graft-vs.-host disease correlates with the disparity for the PECAM-1 S536N polymorphism only in the HLA-B44-like positive Tunisian recipients of HSCs
Sellami, Mohamed Hichem
Ladeb, Saloua
Kaabi, Houda
Cherif, Ghaya
Torjemane, Lamia
Ben Othman, Tarek
Hmida, Slama
CELLULAR IMMUNOLOGY, 2010, 265 (02) : 172 - 178
[46] Hyperacute graft-vs.-host disease after related HLA-identical umbilical cord blood transplantation
Kuskonmaz, Baris
Gocer, Safak
Ersoy-Ewans, Sibel
Ozman, Fatma Cetin
Cetin, Mualla
Uckan, Duygu
PEDIATRIC TRANSPLANTATION, 2007, 11 (07) : 818 - 820
[47] Allogeneic bone marrow transplantation for hepatocellular carcinoma: hepatocyte growth factor suppresses graft-vs.-host disease
Yoshida, Yasuhiko
Hirano, Tadamichi
Son, Gakuhei
Iimuro, Yuji
Imado, Takehito
Iwasaki, Tsuyoshi
Fujimoto, Jiro
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2007, 293 (06): : G1114 - G1123
[48] BIOLOGY OF GRAFT-VS-HOST DISEASE
KORNGOLD, R
AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1993, 15 (01): : 18 - 27
[49] Quantitative assessment of hematopoietic chimerism after allogeneic bone marrow transplantation has predictive value for the occurrence of irreversible graft failure and graft-vs.-host disease
Gyger, M
Baron, C
Forest, L
Lussier, P
Lagacé, F
Bissonnette, I
Bélanger, R
Bonny, Y
Busque, L
Roy, DC
Perreault, C
EXPERIMENTAL HEMATOLOGY, 1998, 26 (05) : 426 - 434
[50] Immunomodulatory Effects of Histone Deacetylation Inhibitors in Graft-vs.-Host Disease After Allogeneic Stem Cell Transplantation
Xu, Xiaoxiao
Li, Xiaoqin
Zhao, Yanmin
Huang, He
FRONTIERS IN IMMUNOLOGY, 2021, 12

← 1 2 3 4 5 →